Navigation Links
P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth
Date:10/30/2007

Raises Fiscal Year EPS Outlook for One-time Tax Benefit

CINCINNATI, Oct. 30, 2007 /PRNewswire-FirstCall/ -- The Procter & Gamble Company (NYSE: PG) announced net sales growth of eight percent to $20.2 billion for the quarter. Every reportable segment delivered mid-single digit or higher sales growth. Organic sales were up five percent for the quarter, in-line with the company's four to six percent target growth range. The Fabric & Home Care, Baby & Family Care and Grooming segments led the growth behind continued strong results on product initiatives across the globe.

Earnings per share were up 16 percent to $0.92 per share, including a one- time tax benefit which increased EPS by $0.02 per share. The company's EPS growth, excluding the one-time benefit, was 14 percent. Earnings per share grew primarily behind strong sales growth and a 30-basis point improvement in operating margin. The company raised its fiscal year EPS outlook by $0.02 to reflect the one-time tax benefit.

"The fiscal year is off to a good start," said A.G. Lafley, Chairman of the Board and Chief Executive Officer. "P&G continues to deliver broad-based top and bottom-line growth across its portfolio of businesses and geographies. This momentum, along with a robust initiative pipeline for the year, gives us confidence that P&G will deliver another strong year of growth."

Executive Summary

-- Net sales increased eight percent to $20.2 billion behind five percent

volume growth. Growth was broad-based with 15 of the company's top 16

countries delivering year-on-year volume growth.

-- Organic sales and volume increased five percent with each geographic

region and every reportable segmen
'/>"/>

SOURCE The Procter & Gamble Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Autopsy reports could be valuable and informative
2. China reports declining number of SARS Cases
3. Russia Reports First SARS Case
4. Research reports that c-section deliveries are rising
5. Jharkhand reports 13,000 Malaria cases
6. Uganda Reports Failure To Contain Sleeping Sickness
7. WHO reports 36 million deaths world wide due to chronic diseases
8. Reports of Hantavirus infection in India raise concerns
9. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
10. China Reports Yet Another Bird Flu Case
11. China reports seventh bird flu victim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...sition in 2009 Continues Growth Trend , , NORTH...-- IPC The Hospitalist Company, Inc. (Nasdaq: IP...up practice company, announced today that it has a...Care Consultants, Inc. (MACC) in St. Louis, Missou... in the St. Louis market, where IPC has establishe...
(Date:1/8/2009)...n. 8 /PRNewswire-Asia/ -- Chindex International, I...a leading independent American,provider of Wester... Republic,of China, today announced that the Comp...ence, to be held in Shanghai on January 12th and 1...e will be held at the Pudong Shangri-,La hotel in...
(Date:1/8/2009)...8 A new educational Web...nce on drugs, biological products and medical devi...ality,s Centers for Education and Research on Ther... more than a dozen leading research centers nation...rmation Network ( CHAIN ) http://www.chainonline....
(Date:1/8/2009)...PRNewswire-FirstCall/ -- Cephalon, Inc . (Nasdaq:... Ph.D., Chairman and CEO will present at the J.P....ry 13, 2009 in San Francisco, CA at approximately ...presentation will be webcast live on the investor ..., The webcast will be archived for one week follow...
Breaking Medicine News(10 mins):Health News:IPC The Hospitalist Company Acquires Missouri Practice Group 2Health News:Chindex International Inc. Announces Participation in the 2009 UBS Greater China Conference 2Health News:AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3
...as accused the NHS of giving false information sin...r undergoing treatment// to remove a non-viable fe...told her that the fetus in her womb was dead. Afte...move the fetus on July 13, but after three weeks s...
...Department of Agriculture (USDA) has made availabl...trition Program// for Women, Infants and Children,... look at reducing the quantity of eggs, milk and j...proposal has indicated that the monthly quota for ...
...ion published a study in the August issue of their...t vegan diet is more effective in treating// type-...fect may be even better than single agent therapy ...n four disease markers; blood sugar control, chole...
...e journal, Cell Metabolism, researchers have descr...that are remarkably similar to those observed// in... aid in finding new therapies for the disease. ...ish becoming an important animal model to better u...
Other Medicine News:Health News:Proposal to revamp WIC food package 2Health News:New Studies On Zebrafish Could Aid in Treating Birth Defects 2Health News:New Studies On Zebrafish Could Aid in Treating Birth Defects 3Health News:New Studies On Zebrafish Could Aid in Treating Birth Defects 4
(Date:1/8/2009)...o, Jan. 8 IntelligentMDx a develope...ays, today announced that verification studies of ... complete. , , Under the verification protocol...d reproducibility and robustness of the BK Viral Q... agreed with internally generated analytical perfo...
(Date:1/7/2009).../ -- ImQuest Life Sciences announced today the suc...od and Drug Administration to initiate human clini...bitor IQP-0410. ImQuest anticipates initiating the...QP-0410 is a novel small molecule inhibitor of HIV...ranscriptase inhibitor (NNRTI). The compound posse...
(Date:1/6/2009)...intaining a healthy immune system , , PURCHASE,... study in Nutrition and Cancer (60(5), 643-651) ...ka, Japan has shown that AHCC (Active Hexose Corre...sing the number of dendritic cells (DCs). DCs are ...esenting foreign substances to other immune system...
(Date:1/6/2009)...wswire/ -- Pacira Pharmaceuticals, Inc., an,acute...today that enrollment,has been completed in two p...fety and efficacy of a single intraoperative admin...olonged postoperative analgesia. , Results ...knee,arthroplasty (TKA) are expected to provide t...
Breaking Medicine Technology:Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 3ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3Piedmont Heart Institute Welcomes Cardiology of Georgia 4327 1Piedmont Heart Institute Welcomes Cardiology of Georgia 4327 2Piedmont Heart Institute Welcomes Cardiology of Georgia 4327 3Piedmont Heart Institute Welcomes Cardiology of Georgia 4327 4Major Deficiencies in Design 3B Funding of Clinical Trials Affects Future of Scientific Innovation 1656 1Major Deficiencies in Design 3B Funding of Clinical Trials Affects Future of Scientific Innovation 1656 2Major Deficiencies in Design 3B Funding of Clinical Trials Affects Future of Scientific Innovation 1656 3Major Deficiencies in Design 3B Funding of Clinical Trials Affects Future of Scientific Innovation 1656 4Major Deficiencies in Design 3B Funding of Clinical Trials Affects Future of Scientific Innovation 1656 5Major Deficiencies in Design 3B Funding of Clinical Trials Affects Future of Scientific Innovation 1656 6Major Deficiencies in Design 3B Funding of Clinical Trials Affects Future of Scientific Innovation 1656 7Cure HIV Reaches Out to Foundation Community to Fund LiSAVIOR 4323 1Cure HIV Reaches Out to Foundation Community to Fund LiSAVIOR 4323 2Laureate Pharma Reports Record Growth for 2007 4321 1Laureate Pharma Reports Record Growth for 2007 4321 2Laureate Pharma Reports Record Growth for 2007 4321 3
...ewswire-FirstCall/ --,Tapestry Pharmaceuticals, In...t the 2007 American Association for Cancer Researc...s, Calif.,Scientists from Tapestry Pharmaceuticals...ad compound, TPI 287, in a poster,presentation ent...d,contributes to antitumor activity in the U251 gl...
...r 15, 2007 - An alarming study,that appeared in th...ournal of the American Cancer Society), reports th...r regimen of the hormonal breast,cancer treatment ...According to the authors, non-compliance with tamo... affect treatment efficacy.,While tamoxifen tablet...
Other Medicine Technology:Tapestry Pharmaceuticals to Present Data on TPI 287 at the 2007,AACR Annual Meeting 2Tapestry Pharmaceuticals to Present Data on TPI 287 at the 2007,AACR Annual Meeting 3Tapestry Pharmaceuticals to Present Data on TPI 287 at the 2007,AACR Annual Meeting 4One-Third of Patients Discontinue Common Breast Cancer Therapy 2One-Third of Patients Discontinue Common Breast Cancer Therapy 3
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products: